Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

@article{Loria2008StudyOT,
  title={Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide},
  author={F. Loria and S. Petrosino and L. Mestre and A. Spagnolo and F. Correa and M. Hernang{\'o}mez and C. Guaza and V. Di Marzo and F. Docagne},
  journal={European Journal of Neuroscience},
  year={2008},
  volume={28}
}
Cannabinoids have recently been approved as a treatment for pain in multiple sclerosis (MS). Increasing evidence from animal studies suggests that this class of compounds could also prove efficient to fight neurodegeneration, demyelination, inflammation and autoimmune processes occurring in this pathology. However, the use of cannabinoids is limited by their psychoactive effects. In this context, potentiation of the endogenous cannabinoid signalling could represent a substitute to the use of… Expand
92 Citations
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
  • 45
  • Highly Influenced
  • PDF
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
  • 21
  • Highly Influenced
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
  • 16
  • Highly Influenced
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis : Clues for other neuroin fl ammatory diseases
  • Valerio Chiurchiùa, Mario van der Steltc, Diego Centonzed, Mauro Maccarronea
  • 2017
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease
  • 12
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Cannabinoids, multiple sclerosis and neuroprotection
  • 15
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis
  • 117
  • PDF
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
  • 128
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis.
  • 26
  • Highly Influential
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
  • 101
  • PDF
Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis
  • 210
  • PDF
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.
  • 137
  • PDF
Drug Insight: effects mediated by peroxisome proliferator-activated receptor-γ in CNS disorders
  • 86
...
1
2
3
4
5
...